FDA Clearance Boosts Tempus AI (TEM) Shares
Following a regulatory approval, shares of Tempus AI, Inc. (NASDAQ: TEM) are experiencing a notable surge on the stock charts today. As of the latest market update, TEM stock had climbed 7.72%, reaching $33.21. This increase reflects investor optimism following the company’s significant milestone. Regulatory Milestone For Tempus ECG-AF Device By receiving the FDA’s 510(k) […]